Matches in SemOpenAlex for { <https://semopenalex.org/work/W4240908764> ?p ?o ?g. }
- W4240908764 endingPage "932" @default.
- W4240908764 startingPage "923" @default.
- W4240908764 abstract "Several drugs approved for a variety of indications have been shown to exhibit antiangiogenic effects. Our study focuses on the PPARγ ligand rosiglitazone, a compound widely used in the treatment of type 2 diabetes. We demonstrate, for the first time to our knowledge, that PPARγ is highly expressed in tumor endothelium and is activated by rosiglitazone in cultured endothelial cells. Furthermore, we show that rosiglitazone suppresses primary tumor growth and metastasis by both direct and indirect antiangiogenic effects. Rosiglitazone inhibits bovine capillary endothelial cell but not tumor cell proliferation at low doses in vitro and decreases VEGF production by tumor cells. In our in vivo studies, rosiglitazone suppresses angiogenesis in the chick chorioallantoic membrane, in the avascular cornea, and in a variety of primary tumors. These results suggest that PPARγ ligands may be useful in treating angiogenic diseases such as cancer by inhibiting angiogenesis." @default.
- W4240908764 created "2022-05-12" @default.
- W4240908764 creator A5014291500 @default.
- W4240908764 creator A5014909897 @default.
- W4240908764 creator A5026584268 @default.
- W4240908764 creator A5028523107 @default.
- W4240908764 creator A5031756094 @default.
- W4240908764 creator A5034761457 @default.
- W4240908764 creator A5034908463 @default.
- W4240908764 creator A5040359760 @default.
- W4240908764 creator A5045261329 @default.
- W4240908764 creator A5050651568 @default.
- W4240908764 creator A5068990029 @default.
- W4240908764 creator A5072876748 @default.
- W4240908764 creator A5075631226 @default.
- W4240908764 creator A5082159954 @default.
- W4240908764 creator A5088978035 @default.
- W4240908764 date "2002-10-01" @default.
- W4240908764 modified "2023-10-17" @default.
- W4240908764 title "PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis" @default.
- W4240908764 cites W1502713173 @default.
- W4240908764 cites W1549631663 @default.
- W4240908764 cites W1579897036 @default.
- W4240908764 cites W1633340712 @default.
- W4240908764 cites W1964556827 @default.
- W4240908764 cites W1968703258 @default.
- W4240908764 cites W1975160900 @default.
- W4240908764 cites W1976621212 @default.
- W4240908764 cites W1977252673 @default.
- W4240908764 cites W1984348097 @default.
- W4240908764 cites W1985147506 @default.
- W4240908764 cites W1989619519 @default.
- W4240908764 cites W1993342645 @default.
- W4240908764 cites W1993866602 @default.
- W4240908764 cites W1994937581 @default.
- W4240908764 cites W1997172664 @default.
- W4240908764 cites W2002519246 @default.
- W4240908764 cites W2006340844 @default.
- W4240908764 cites W2006388846 @default.
- W4240908764 cites W2008786326 @default.
- W4240908764 cites W2014385323 @default.
- W4240908764 cites W2016443141 @default.
- W4240908764 cites W2018206586 @default.
- W4240908764 cites W2026151657 @default.
- W4240908764 cites W2031694725 @default.
- W4240908764 cites W2053242629 @default.
- W4240908764 cites W2072928113 @default.
- W4240908764 cites W2086376157 @default.
- W4240908764 cites W2091321756 @default.
- W4240908764 cites W2095378845 @default.
- W4240908764 cites W2113328569 @default.
- W4240908764 cites W2120427107 @default.
- W4240908764 cites W2126426760 @default.
- W4240908764 cites W2159789252 @default.
- W4240908764 cites W2311972351 @default.
- W4240908764 cites W2322564302 @default.
- W4240908764 cites W4240507531 @default.
- W4240908764 doi "https://doi.org/10.1172/jci0215634" @default.
- W4240908764 hasPublicationYear "2002" @default.
- W4240908764 type Work @default.
- W4240908764 citedByCount "240" @default.
- W4240908764 countsByYear W42409087642012 @default.
- W4240908764 countsByYear W42409087642013 @default.
- W4240908764 countsByYear W42409087642014 @default.
- W4240908764 countsByYear W42409087642015 @default.
- W4240908764 countsByYear W42409087642016 @default.
- W4240908764 countsByYear W42409087642017 @default.
- W4240908764 countsByYear W42409087642018 @default.
- W4240908764 countsByYear W42409087642019 @default.
- W4240908764 countsByYear W42409087642020 @default.
- W4240908764 countsByYear W42409087642021 @default.
- W4240908764 countsByYear W42409087642022 @default.
- W4240908764 countsByYear W42409087642023 @default.
- W4240908764 crossrefType "journal-article" @default.
- W4240908764 hasAuthorship W4240908764A5014291500 @default.
- W4240908764 hasAuthorship W4240908764A5014909897 @default.
- W4240908764 hasAuthorship W4240908764A5026584268 @default.
- W4240908764 hasAuthorship W4240908764A5028523107 @default.
- W4240908764 hasAuthorship W4240908764A5031756094 @default.
- W4240908764 hasAuthorship W4240908764A5034761457 @default.
- W4240908764 hasAuthorship W4240908764A5034908463 @default.
- W4240908764 hasAuthorship W4240908764A5040359760 @default.
- W4240908764 hasAuthorship W4240908764A5045261329 @default.
- W4240908764 hasAuthorship W4240908764A5050651568 @default.
- W4240908764 hasAuthorship W4240908764A5068990029 @default.
- W4240908764 hasAuthorship W4240908764A5072876748 @default.
- W4240908764 hasAuthorship W4240908764A5075631226 @default.
- W4240908764 hasAuthorship W4240908764A5082159954 @default.
- W4240908764 hasAuthorship W4240908764A5088978035 @default.
- W4240908764 hasBestOaLocation W42409087641 @default.
- W4240908764 hasConcept C121608353 @default.
- W4240908764 hasConcept C123012128 @default.
- W4240908764 hasConcept C126322002 @default.
- W4240908764 hasConcept C134018914 @default.
- W4240908764 hasConcept C150903083 @default.
- W4240908764 hasConcept C170493617 @default.
- W4240908764 hasConcept C202751555 @default.
- W4240908764 hasConcept C207001950 @default.